Xvivo Perfusion AB (publ) (FRA:3XV)

Market Cap	544.56M
Revenue (ttm)	73.59M
Net Income (ttm)	2.70M
Shares Out	n/a
EPS (ttm)	0.09
PE Ratio	201.35
Forward PE	57.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8
Open	16.80
Previous Close	16.63
Day's Range	16.80 - 16.80
52-Week Range	14.45 - 44.40
Beta	n/a
RSI	56.30
Earnings Date	Jan 27, 2026

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 190
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 3XV

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.

Financial numbers in SEK